GeneArrest
2009
FOUNDED
OOB
STATUS
11-20
EMPLOYEES
Out of Business
LATEST DEAL TYPE
Description
Developer of an anti-gene drug platform. The company develops a computational design of modular polymers that bind a specific sequence of DNA.
Website
Formerly Known As
Antigene Biotechnologies
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- POB 1252, Nazareth Industrial Area
- NGT incubator, Sami Shahin building
- Nazareth 16000
- Israel
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore GeneArrest’s full profile, request a free trial.
GeneArrest Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | Completed | Out of Business | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
GeneArrest Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Mizied Falah Ph.D | Co-Founder & Chief Technology Officer | ||
| Anwar Rayan Ph.D | Co-Founder & Chief Executive Officer |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »